Skip to main content
Erschienen in: Clinical Oral Investigations 10/2023

Open Access 17.08.2023 | Research

The molecular weight of hyaluronic acid influences metabolic activity and osteogenic differentiation of periodontal ligament cells

verfasst von: Iris Frasheri, Nikoletta Dimitra Tsakiridou, Reinhard Hickel, Matthias Folwaczny

Erschienen in: Clinical Oral Investigations | Ausgabe 10/2023

Abstract

Objective

While HA is present naturally in periodontal tissues, its molecular weight can vary widely in vivo. The objective of this study was to directly compare the biological reactions of periodontal ligament cells to four distinct molecular weights of hyaluronic acid (HA).

Materials and methods

Immortalized human periodontal ligament cells (PDL-hTERT) were cultured for 21 days in culture medium alone (control) or enriched with osteogenic supplements (OS group). Other 4 experimental groups were cultured in OS medium with the addition of HA with different molecular weights (HMW, MMW, LMW, and ULMW). The cell morphology was examined daily. WST1 assays were performed to evaluate metabolic activity. Von Kossa staining and calcium deposition assay were used to analyze osteogenic differentiation and mineralization.

Results

Cell morphology remained unaltered in all groups. Cells stimulated with OS alone or with the addition of hyaluronan showed all the typical microscopic appearance of osteogenic differentiation. Metabolic activity increased in all groups over time. Hyaluronan stimulated greater metabolic activity than the control group, with LMW HA and MMW HA showing the most significant increase. All groups showed mineral deposits and calcium deposition after 21 days of stimulation.

Conclusion

Our results suggest that hyaluronan can promote metabolic activity and mineralization of PDL-hTERT cells, with LMW HA being the most effective.

Clinical relevance

These results shed light on how the various molecular weight fractions of HA promote tissue regeneration and repair, as well as help to identify an optimal molecular weight range for this application in periodontal tissues.
Hinweise

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Periodontitis is a chronic inflammatory disease that affects the supporting structures of teeth, including the periodontal ligament and alveolar bone [1]. The extracellular matrix of these tissues is primarily composed of a network of glycosaminoglycans (GAGs) [2], among which hyaluronic acid (HA) plays a crucial role. HA is a linear polymer of repeating disaccharide units of glucuronic acid and N-acetylglucosamine [3], and its molecular weight (MW) can vary widely in vivo, ranging from ultra-low (ULMW) to high (HMW) molecular weight [4].
This non-sulfated glycosaminoglycan HA in its native form is present as a long linear polysaccharide having a high-molecular weight >1000kDa (HMW HA) [5, 6]. Three hyaluronan synthase enzymes are responsible for the synthesis of HA and its release of the protein into the intercellular space HAS 1, 2 and 3 [7].
HA has been found to be present naturally in periodontal tissues, gingival connective tissues as well as gingival epithelium [8, 9] produced/synthesized by the hyaluronan synthases at the plasma membrane [10, 11] of various cells in the periodontal area including epithelial rest of Malassez cells [12], and periodontal ligament cells, with fibroblasts being the primary cell type responsible for the synthesis of HA in the periodontal tissues [13]. Particularly, Utsunomiya et al. found HA to be more localized at edematous/mixoid areas of the periodontal ligament than in compact fibrous areas [9].
The content of HA in human gingival epithelium has been calculated to be circa 5.58 μg/g dry wt., while in human gingival connective tissue circa 126.4 μg/g dry wt. [8].
Several studies have suggested an important role for hyaluronan in maintaining periodontal tissue homeostasis [14]. Moreover, HA has been shown to regulate inflammatory responses by modulating the activity of immune cells, particularly neutrophil functions [15, 16], and regulating cytokine expression [17]. Furthermore, it has been proposed that the presence of HA in periodontal tissues could play a key role in regulating cell proliferation, differentiation, and wound healing [18].
In case of inflammation, hyaluronidases, the activity of reactive oxygen and nitrogen species, etc. induce the HA into smaller fragments of different MW [19, 20]. In fact, while in healthy gingiva there is a predominance of native HA, it has been evidenced that in gingiva of patients with periodontal disease there is a shift towards low-molecular size glycosaminoglycans [21].
The amount of hyaluronan, specifically the low-molecular weight HA (LMW HA) present in the gingival crevicular fluid (GCF) has been seen to be higher in patients affected by periodontitis, even after periodontal therapy [22].
These apparently different involvements of HA, support the suggestion of Wu et al, that studying HA in knee osteoarthritis, suggested that HA of different MW present peculiar features and they should be not considered as a single group [23].
Even having evidenced the presence of fractions with a different molecular weight HA, the present available literature is scarce in comparing their effects in the periodontal tissues.
Understanding the effects of different molecular weight fractions of HA on PDL cells is important for elucidating the mechanisms involved in periodontal tissue maintenance and repair. By investigating these effects, we can also gain insight into the optimal molecular weight range for promoting tissue regeneration and repair.
Thus, the aim of this study was to directly compare and better understand the biological reactions of PDL-hTERT cells to four distinct molecular weights of hyaluronan.

Materials and methods

Cell culture

Human immortalized periodontal ligament cells (PDL-hTERT) were established as previously described [24]. PDL-hTERT cells were maintained at 5% CO2 and 37°C in Dulbecco's Modified Eagle Medium (DMEM, high glucose, +Glutamine, +Pyruvate) enriched with 10% fetal bone serum, 1% Pen-Strep solution and 2mM L-glutamine (all Sigma Aldrich, Munich, Germany). Medium change was performed twice a week.

Stimulating conditions and cell morphology

A control group of PDL-hTERTs was cultured in DMEM enriched as described above, without any hyaluronan supplements. Another group was constituted of PDL-hTERTs cultured in osteogenic differentiation medium (OS), which was DMEM with osteogenic supplement: 10% FBS, 1% Pen-Strep, 100nM Dexamethasone, 10mM β-glycerol phosphate and 50μM L-ascorbic acid (Sigma Aldrich, Munich, Deutschland).
Hyaluronan (HA) with different molecular weights was purchased from R&D Systems, Minneapolis, MN, USA. The four groups further used for the experiments were as follows: High Molecular Weight Hyaluronan (HMW), Medium Molecular Weight Hyaluronan (MMW), Low Molecular Weight Hyaluronan (LMW), and Ultra Low Molecular Weight Hyaluronan (ULMW). HMW hyaluronan is provided by the company in a molecular mass range of >950kDa. The specific lot used had a mass of 1510kDa. MMW hyaluronan presents a molecular mass range of 75–350kDa. The lot used had a mass of 229kDa. LMW hyaluronan has a molecular mass range of 15–40kDa. The specific lot used had a mass of 37kDa. ULMW hyaluronan is in a molecular mass range of 4–8kDa. The specific lot used had a mass of 4.6kDa. HA was reconstituted as per manufacturer´s indications in phosphate buffered saline and sterilized by filtration with 0.2-μm syringe filters (VWR International, Radonor, USA). The stimulating concentration of 100μg/ml was further used in the experimental groups, and it was determined based on previous studies [25, 26]. PDL-hTERTs between the 27th and the 29th passage were used. PDL-hTERT were cultured in 1 ml medium, at 2x 104 cells/well in 12-well plates for 3 weeks.
The cell morphology was examined daily, and photographs were taken using a phase contrast microscope (Axiovert, Carl Zeiss, Jena, Germany). For each studied group, the experiments were performed in triplicates and repeated three times.

Metabolic activity

Water-soluble tetrazolium-1 (WST-1) assays were performed. For this assay, PDL-hTERTs were seeded in 24-well plates (1x104 cells/well) and cultured for 7, 14, or 21 days, exposed to the above-mentioned HA solutions (HMW, MMW, LMW and ULMW). The groups with medium alone and OS medium were also cultured under the same conditions. Medium change with 0.5 ml per well was performed every 2 days. At each experiment day, WST-1 (Roche Diagnostics GmbH, Mannheim, Germany) was added according to manufacturer’s protocols in a 1:10 final dilution, incubated for 1 hour (5% CO2 and 37°C). The medium of each well was transferred into two wells of a 96-well plate, with a volume of 100 μl per well. The optical density of the samples was measured through a multi-detection microplate reader (TECAN, Infinite M200, Männedorf, Switzerland). Data analyses were performed with Magellan™ Software (TECAN). Absorbance readings were recorded at 450nm, with a wavelength correction at 650nm. The experiments were performed in triplicates and repeated three times.

Von Kossa

Von Kossa staining was used to analyze mineralization in cell cultures in the six study groups.
PDL-hTERT were seeded at 2x 104 cells/well in 12-well plates and cultured for 21 days in the same media as described above. The respective media were replaced twice a week.
The cells were afterwards fixed for 20 min in methanol at -20°C. The standard protocol was used for the staining with silver nitrate (Merck KGaA, Darmstadt, Germany), pyrogallol acid solution (University Pharmacy, Munich, Germany), sodium hydroxide solution (Merck KGaA, Darmstadt, Germany) and May-Grünwald solution (Merck KGaA, Darmstadt, Germany). Afterwards, pictures were taken in standardized conditions for all groups.

Calcium deposition assay

PDL-hTERTs in the 28th passage were plated at a concentration of 2x 104 cells/well in 12-well plates and divided into 6 groups as above: control; +OS; +OS+ HMW, +OS+ MMW, +OS+ LMW and +OS+ ULMW. The cells were stimulated for 21 days and then harvested with QuantiChromTM Calcium Assay Kit (Bioassay Systems, Basel, Switzerland) following manufacturer´s protocol. The calcium quantification was done with a microplate reader (TECAN, Infinite M200, Männedorf, Switzerland). The measurements were performed at 612 nm and the calculations of calcium deposition in mg/dl were done establishing a standard curve as per manufacturer´s indications.

Statistics

Statistical analyses were performed using SPSS software (Version 26.0, SPSS Statistics, IBM, Chicago, IL, USA). Within each group, data were tested for normality with the Kolmogorov-Smirnov and Shapiro-Wilk tests. Homogeneity of variances between groups was tested with Levene test. Since data were not normally distributed, differences between study groups in calcium deposition for each time point were calculated with the Mann-Whitney U test and with Games-Howell test for WST-1. The p-value threshold was set at 0.05. If not otherwise indicated, all data are given as mean ± standard deviation (±SD).

Results

Cell morphology

The single cell morphology remained unaltered in all groups, which presented an elongated spindle shaped form (Fig. 1). The cells grew in a monolayer with increased density until day 7. During the second week in culture, they formed a rolled aggregate with oval-shaped, cell-free areas, typical of osteogenic differentiation. This was observed in all groups stimulated with osteogenic medium, as well as in the ones with hyaluronan supplements but, as expected, not in the control. Hyaluronan did obviously not induce any morphological changes in PDL-hTERT cells irrespectively from the particular molecular weight (Fig. 1).

Metabolic activity

Considering the changes within the single study groups overtime, in all six groups, the cells´ activity increased with time, so that the highest value was measured for all groups on the 21st day. The osteogenic and the control groups increased equally within the observed time intervals and reached comparable values (Fig. 2). Accordingly, there was no significant difference between the two groups (p> 0.05). The maximum increase in cell activity within the observed 21 days was seen in the cells stimulated with LMW and MMW. While the cells stimulated with MMW showed a higher difference in their metabolic activity from day 7 to day 14, this was more the case between day 14 and 21 for the cells stimulated with LMW. Moreover, it can be observed that the groups stimulated with HMW, MMW and ULMW hyaluronan presented at day 14 significantly higher metabolic activity than the control group.
A significant difference (p<0.05) between HMW group and ULMW can also be observed at day 7, which, however, could no longer be detected at day 14. At day 21, all groups stimulated with hyaluronic acid presented higher values than the control, but also higher than the OS group, but this reached significance just for LMW and MMW in the comparison with the control.

Mineralization

We next assessed the capacity of PDL-hTERT cells stimulated with different molecular weight hyaluronan to differentiate into osteoblasts capable of forming a mineralized extracellular matrix. Mineral deposits by PDL-hTERTs were identified by von Kossa staining technique in all groups after 21 days of stimulation. Photographs of representative cultures are shown in Fig. 3.
The mineralization was also quantified in parallel experiments by calcium deposition assay (Fig. 4). Spectrophotometric quantification confirmed these observations, revealing a significantly increased absorbance at 450 nm and calculated calcium deposition, for the cells stimulated with LMW. The osteogenic parameters investigated were decreased in the group stimulated with HMW, but this difference did not reach significance.

Discussion

The current study aimed to determine the influence of fragments of hyaluronic acid with varying molecular weights on periodontal ligament cells. This influence was evaluated first on the morphological, phenotypical expression of PDL-hTERTs, and then on the capacity of these cells to differentiate into osteoblasts, as described by Docheva et al. [24]. The PDL-hTERTs were specifically chosen due to their multipotent properties.
Furthermore, these fibroblasts are the main cells occurring in the periodontal crevicular space, performing several functions in periodontal regeneration and homeostasis [27, 28]. Consequently, they represent an appropriate experimental model for investigations in the context of periodontal therapy after adequate stimulation. In order to provide a comprehensive overview, we used four different sizes of hyaluronic acid, all applied at the same concentration to allow better comparison.
Regarding microscopic appearance, osteogenically stimulated PDL-hTERTs as well as those additionally treated with any of the fragments of HA showed an ongoing osteogenic differentiation at day 14. Contrarily to the control, all treated groups exhibited oval-shaped, cell-free areas that are typical of the beginning of mineralization/osteogenic differentiation. No differences were seen to be induced in cell morphology by HA, compare to OS alone. This has also been demonstrated by Kawano et al. for HMW hyaluronic acid of more than 2000kDa [29]. However, in this study, no other hyaluronan fragments were tested.
Analyzing metabolic activity, we observed a significant increase in PDL-hTERTs proliferation treated with MMW HA, already at day 7, until the end of the observation period, after 21 days, which is greater than the control and any hyaluronan with different MW. Similar results were found for the proliferation rate of skin keratinocytes by Ghazi et al., who hypothesized that MMW HA is a more effective therapeutic approach than native HA for promoting wound healing [30]. In line with this, a clinical study showed that the topical use of HMW HA reduces cell proliferation in fibroblasts, epithelial cells, lymphocytes, etc. [31]. Also an in vitro study on dental pulp stem cells showed that LMW HA induces a proliferation rate that is two times higher than that of HMW HA.
A recent study conducted on hamster ovary cells demonstrated that the application of sodium hyaluronate with a molecular weight > 1300kDa [32] inhibits proliferation in a concentration-dependent manner [33], particularly for concentrations > 0.5mg/ml. In the current study, we observed lower metabolic activity in PDLhTERTs treated with HMW HA at day 7, although not reaching significance. However, at day 14, there was a significant increase in metabolic activity. Nevertheless, the anti-inflammatory functions of high molecular weight hyaluronate may be a key factor in its efficacy for periodontal applications, as suggested by previous research [6]. According to results obtained by Tanimoto et al., HA may contribute to regulating this proliferation of human PDL cells through a mechanism mediated by CD44 [34].
The effect of LMW HA has been analyzed in 3D culture models and it has been demonstrated to enhance osteogenesis and bone matrix formation [35]. This is consistent with our results, which showed a significantly higher deposition of calcium salts after 21 days of treatment with LMW HA.
In contrast, ULMW HA in our study appeared to have no effect on cell morphology or mineralization potential of PDL-hTERTs. However, it induced a greater metabolic activity in PDL-hTERTs at the beginning of their osteogenic differentiation, at day 7 and 14.
In a study by Ariyoshi et al. [36], HA with a molecular weight of less than 8kDa HA, comparable to our ULMW HA, seemed to also enhance bone resorption, upregulating osteoclast differentiation.
It is worth considering that the biological effects HA can be cell type or tissue specific, as suggested by Cowman et al. [4]. Therefore, HA fragments of varying sizes can assume different roles, as the levels of the receptors or of signaling proteins are heterogeneous in different areas [37]. Additionally, several studies use different concentrations as well as slightly different ranges to define the various molecular weight fractions of HA (in kDa), which can make comparisons challenging. From this point of view, our study has the advantage of directly comparing multiple fractions, thus providing a more comprehensive understanding of their effects. At last, another important point to consider in comparing the functional effects of hyaluronic acid is that different animal species present a different MW HA which is physiologically more present in a specific tissue.
A limitation of this study is that it is performed with immortalized PDL cells isolated from one donor and, therefore, might not be representative of a general population. Another limitation of our study is that being an in vitro study, it lacks the possible mutual influence between HA fragments and the surrounding tissues, as these interactions influence the growth microenvironment of the cells regulating the HA response [38].
In the light of our results, the molecular weight of the local HA could be used for its potential predictive value in amplifying periodontal regenerative healing. In terms of the current results particularly HA fragments with medium molecular weight are promising candidates to further delineate the regenerative potential of glycosaminoglycans, specifically HA.
Also, the concentration of HA fragments might influence the obtained cell effects. Thus, further studies might consider covering a wider range for HA concentrations. It might be also interesting to investigate combined effects of HA with different molecular weights, as a bio-synergistic impact of two distinct molecular weights of HA was also proposed by Rosaming et al. [39].

Conclusions

Overall, our in vitro findings suggest that the molecular weight of HA may play a key role in regulating the mineralization of periodontal tissues, and further investigation is needed to improve the understanding of the underlying biological mechanisms involved.

Acknowledgements

The authors want to thank Brigitte Hackl for her continuous technical support.

Declarations

Not applicable.

Conflict of interest

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Jetzt e.Med zum Sonderpreis bestellen!

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt bestellen und 100 € sparen!

e.Dent – Das Online-Abo der Zahnmedizin

Online-Abonnement

Mit e.Dent erhalten Sie Zugang zu allen zahnmedizinischen Fortbildungen und unseren zahnmedizinischen und ausgesuchten medizinischen Zeitschriften.

Literatur
1.
Zurück zum Zitat Kononen E, Gursoy M, Gursoy UK (2019) Periodontitis: A Multifaceted Disease of Tooth-Supporting Tissues. J Clin Med 8(8) Kononen E, Gursoy M, Gursoy UK (2019) Periodontitis: A Multifaceted Disease of Tooth-Supporting Tissues. J Clin Med 8(8)
2.
Zurück zum Zitat Coulson-Thomas YM et al (2015) The identification of proteoglycans and glycosaminoglycans in archaeological human bones and teeth. PLoS One 10(6):e0131105CrossRefPubMedPubMedCentral Coulson-Thomas YM et al (2015) The identification of proteoglycans and glycosaminoglycans in archaeological human bones and teeth. PLoS One 10(6):e0131105CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Agren UM, Tammi RH, Tammi MI (1997) Reactive oxygen species contribute to epidermal hyaluronan catabolism in human skin organ culture. Free Radic Biol Med 23(7):996–1001CrossRefPubMed Agren UM, Tammi RH, Tammi MI (1997) Reactive oxygen species contribute to epidermal hyaluronan catabolism in human skin organ culture. Free Radic Biol Med 23(7):996–1001CrossRefPubMed
6.
Zurück zum Zitat Albano GD et al (2016) Effect of High, Medium, and Low Molecular Weight Hyaluronan on Inflammation and Oxidative Stress in an In Vitro Model of Human Nasal Epithelial Cells. Mediators Inflamm 2016:8727289CrossRefPubMedPubMedCentral Albano GD et al (2016) Effect of High, Medium, and Low Molecular Weight Hyaluronan on Inflammation and Oxidative Stress in an In Vitro Model of Human Nasal Epithelial Cells. Mediators Inflamm 2016:8727289CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Tammi RH et al (2011) Transcriptional and post-translational regulation of hyaluronan synthesis. FEBS J 278(9):1419–1428CrossRefPubMed Tammi RH et al (2011) Transcriptional and post-translational regulation of hyaluronan synthesis. FEBS J 278(9):1419–1428CrossRefPubMed
8.
Zurück zum Zitat Bartold PM, Wiebkin OW, Thonard JC (1981) Glycosaminoglycans of human gingival epithelium and connective tissue. Connect Tissue Res 9(2):99–106CrossRefPubMed Bartold PM, Wiebkin OW, Thonard JC (1981) Glycosaminoglycans of human gingival epithelium and connective tissue. Connect Tissue Res 9(2):99–106CrossRefPubMed
9.
Zurück zum Zitat Utsunomiya T, Otsuka A, Sato R, Yamaguchi M, Kasai K, Yamamoto H, Kuyama K (2014) Immunohistochemical Localization of Versican, Link Protein and Hyaluronic Acid Binding Protein in the Human Periodontal Ligament. Open J Stomatol 4(9):446–451CrossRef Utsunomiya T, Otsuka A, Sato R, Yamaguchi M, Kasai K, Yamamoto H, Kuyama K (2014) Immunohistochemical Localization of Versican, Link Protein and Hyaluronic Acid Binding Protein in the Human Periodontal Ligament. Open J Stomatol 4(9):446–451CrossRef
10.
Zurück zum Zitat Weigel PH, Hascall VC, Tammi M (1997) Hyaluronan synthases. J Biol Chem 272(22):13997–14000CrossRefPubMed Weigel PH, Hascall VC, Tammi M (1997) Hyaluronan synthases. J Biol Chem 272(22):13997–14000CrossRefPubMed
11.
Zurück zum Zitat Yoshida M et al (2000) In vitro synthesis of hyaluronan by a single protein derived from mouse HAS1 gene and characterization of amino acid residues essential for the activity. J Biol Chem 275(1):497–506CrossRefPubMed Yoshida M et al (2000) In vitro synthesis of hyaluronan by a single protein derived from mouse HAS1 gene and characterization of amino acid residues essential for the activity. J Biol Chem 275(1):497–506CrossRefPubMed
12.
Zurück zum Zitat Merrilees MJ, Sodek J, Aubin JE (1983) Effects of cells of epithelial rests of Malassez and endothelial cells on synthesis of glycosaminoglycans by periodontal ligament fibroblasts in vitro. Dev Biol 97(1):146–153CrossRefPubMed Merrilees MJ, Sodek J, Aubin JE (1983) Effects of cells of epithelial rests of Malassez and endothelial cells on synthesis of glycosaminoglycans by periodontal ligament fibroblasts in vitro. Dev Biol 97(1):146–153CrossRefPubMed
13.
Zurück zum Zitat Larjava H et al (1983) Enhanced synthesis of hyaluronic acid by human gingival fibroblasts exposed to human dental bacterial extract. J Periodontal Res 18(1):31–39CrossRefPubMed Larjava H et al (1983) Enhanced synthesis of hyaluronic acid by human gingival fibroblasts exposed to human dental bacterial extract. J Periodontal Res 18(1):31–39CrossRefPubMed
15.
Zurück zum Zitat Jackson DG (2009) Immunological functions of hyaluronan and its receptors in the lymphatics. Immunol Rev 230(1):216–231CrossRefPubMed Jackson DG (2009) Immunological functions of hyaluronan and its receptors in the lymphatics. Immunol Rev 230(1):216–231CrossRefPubMed
16.
Zurück zum Zitat Niemietz I et al (2020) Hyaluronan primes the oxidative burst in human neutrophils. J Leukoc Biol 108(2):705–713CrossRefPubMed Niemietz I et al (2020) Hyaluronan primes the oxidative burst in human neutrophils. J Leukoc Biol 108(2):705–713CrossRefPubMed
17.
Zurück zum Zitat Niemietz I, Brown KL (2023) Hyaluronan promotes intracellular ROS production and apoptosis in TNFalpha-stimulated neutrophils. Front Immunol 14:1032469CrossRefPubMedPubMedCentral Niemietz I, Brown KL (2023) Hyaluronan promotes intracellular ROS production and apoptosis in TNFalpha-stimulated neutrophils. Front Immunol 14:1032469CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Sasaki T, Watanabe C (1995) Stimulation of osteoinduction in bone wound healing by high-molecular hyaluronic acid. Bone 16(1):9–15CrossRefPubMed Sasaki T, Watanabe C (1995) Stimulation of osteoinduction in bone wound healing by high-molecular hyaluronic acid. Bone 16(1):9–15CrossRefPubMed
19.
20.
Zurück zum Zitat Yamazaki K et al (2003) Reactive oxygen species depolymerize hyaluronan: involvement of the hydroxyl radical. Pathophysiology 9(4):215–220CrossRefPubMed Yamazaki K et al (2003) Reactive oxygen species depolymerize hyaluronan: involvement of the hydroxyl radical. Pathophysiology 9(4):215–220CrossRefPubMed
21.
Zurück zum Zitat Yamalik N et al (1998) Molecular size distribution analysis of human gingival proteoglycans and glycosaminoglycans in specific periodontal diseases. J Clin Periodontol 25(2):145–152CrossRefPubMed Yamalik N et al (1998) Molecular size distribution analysis of human gingival proteoglycans and glycosaminoglycans in specific periodontal diseases. J Clin Periodontol 25(2):145–152CrossRefPubMed
22.
Zurück zum Zitat Castillo F et al (2021) Levels of low-molecular-weight hyaluronan in periodontitis-treated patients and its immunostimulatory effects on CD4(+) T lymphocytes. Clin Oral Investig 25(8):4987–5000CrossRefPubMed Castillo F et al (2021) Levels of low-molecular-weight hyaluronan in periodontitis-treated patients and its immunostimulatory effects on CD4(+) T lymphocytes. Clin Oral Investig 25(8):4987–5000CrossRefPubMed
23.
Zurück zum Zitat Wu YZ et al (2021) Molecular Weight of Hyaluronic Acid Has Major Influence on Its Efficacy and Safety for Viscosupplementation in Hip Osteoarthritis: A Systematic Review and Meta-Analysis. Cartilage 13(1_suppl):169S–184SCrossRefPubMedPubMedCentral Wu YZ et al (2021) Molecular Weight of Hyaluronic Acid Has Major Influence on Its Efficacy and Safety for Viscosupplementation in Hip Osteoarthritis: A Systematic Review and Meta-Analysis. Cartilage 13(1_suppl):169S–184SCrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Docheva D et al (2010) Establishment of immortalized periodontal ligament progenitor cell line and its behavioural analysis on smooth and rough titanium surface. Eur Cell Mater 19:228–241CrossRefPubMed Docheva D et al (2010) Establishment of immortalized periodontal ligament progenitor cell line and its behavioural analysis on smooth and rough titanium surface. Eur Cell Mater 19:228–241CrossRefPubMed
25.
Zurück zum Zitat Mast BA et al (1993) Hyaluronic acid modulates proliferation, collagen and protein synthesis of cultured fetal fibroblasts. Matrix 13(6):441–446CrossRefPubMed Mast BA et al (1993) Hyaluronic acid modulates proliferation, collagen and protein synthesis of cultured fetal fibroblasts. Matrix 13(6):441–446CrossRefPubMed
26.
Zurück zum Zitat Rowley JE et al (2020) Low Molecular Weight Hyaluronan Induces an Inflammatory Response in Ovarian Stromal Cells and Impairs Gamete Development In Vitro. Int J Mol Sci 21(3) Rowley JE et al (2020) Low Molecular Weight Hyaluronan Induces an Inflammatory Response in Ovarian Stromal Cells and Impairs Gamete Development In Vitro. Int J Mol Sci 21(3)
27.
Zurück zum Zitat Hasegawa T et al (2010) Establishment of immortalized human periodontal ligament cells derived from deciduous teeth. Int J Mol Med 26(5):701–705CrossRefPubMed Hasegawa T et al (2010) Establishment of immortalized human periodontal ligament cells derived from deciduous teeth. Int J Mol Med 26(5):701–705CrossRefPubMed
28.
Zurück zum Zitat Seo BM et al (2004) Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 364(9429):149–155CrossRefPubMed Seo BM et al (2004) Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 364(9429):149–155CrossRefPubMed
29.
Zurück zum Zitat Kawano M et al (2011) Mechanism involved in enhancement of osteoblast differentiation by hyaluronic acid. Biochem Biophys Res Commun 405(4):575–580CrossRefPubMed Kawano M et al (2011) Mechanism involved in enhancement of osteoblast differentiation by hyaluronic acid. Biochem Biophys Res Commun 405(4):575–580CrossRefPubMed
30.
Zurück zum Zitat Ghazi K et al (2012) Hyaluronan fragments improve wound healing on in vitro cutaneous model through P2X7 purinoreceptor basal activation: role of molecular weight. PLoS One 7(11):e48351CrossRefPubMedPubMedCentral Ghazi K et al (2012) Hyaluronan fragments improve wound healing on in vitro cutaneous model through P2X7 purinoreceptor basal activation: role of molecular weight. PLoS One 7(11):e48351CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Mesa FL et al (2002) Antiproliferative effect of topic hyaluronic acid gel. Study in gingival biopsies of patients with periodontal disease. Histol Histopathol 17(3):747–753PubMed Mesa FL et al (2002) Antiproliferative effect of topic hyaluronic acid gel. Study in gingival biopsies of patients with periodontal disease. Histol Histopathol 17(3):747–753PubMed
32.
Zurück zum Zitat Snetkov P et al (2020) Hyaluronic Acid: The Influence of Molecular Weight on Structural, Physical, Physico-Chemical, and Degradable Properties of Biopolymer. Polymers (Basel) 12(8) Snetkov P et al (2020) Hyaluronic Acid: The Influence of Molecular Weight on Structural, Physical, Physico-Chemical, and Degradable Properties of Biopolymer. Polymers (Basel) 12(8)
33.
Zurück zum Zitat Dube B et al (2001) Hyaluronan reduces migration and proliferation in CHO cells. Biochim Biophys Acta 1538(2-3):283–289CrossRefPubMed Dube B et al (2001) Hyaluronan reduces migration and proliferation in CHO cells. Biochim Biophys Acta 1538(2-3):283–289CrossRefPubMed
34.
Zurück zum Zitat Tanimoto K et al (2008) Inhibition of the proliferation of human periodontal ligament fibroblasts by hyaluronidase. Arch Oral Biol 53(4):330–336CrossRefPubMed Tanimoto K et al (2008) Inhibition of the proliferation of human periodontal ligament fibroblasts by hyaluronidase. Arch Oral Biol 53(4):330–336CrossRefPubMed
35.
Zurück zum Zitat Krieghoff J et al (2019) Increased pore size of scaffolds improves coating efficiency with sulfated hyaluronan and mineralization capacity of osteoblasts. Biomater Res 23:26CrossRefPubMedPubMedCentral Krieghoff J et al (2019) Increased pore size of scaffolds improves coating efficiency with sulfated hyaluronan and mineralization capacity of osteoblasts. Biomater Res 23:26CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Ariyoshi W et al (2005) Mechanisms involved in enhancement of osteoclast formation and function by low molecular weight hyaluronic acid. J Biol Chem 280(19):18967–18972CrossRefPubMed Ariyoshi W et al (2005) Mechanisms involved in enhancement of osteoclast formation and function by low molecular weight hyaluronic acid. J Biol Chem 280(19):18967–18972CrossRefPubMed
37.
Zurück zum Zitat Campoccia D et al (1998) Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials 19(23):2101–2127CrossRefPubMed Campoccia D et al (1998) Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials 19(23):2101–2127CrossRefPubMed
39.
Zurück zum Zitat Rosaming P et al (2022) Interpenetrating Low-Molecular Weight Hyaluronic Acid in Hyaluronic Acid-Based In Situ Hydrogel Scaffold for Periodontal and Oral Wound Applications. Polymers (Basel):14(22) Rosaming P et al (2022) Interpenetrating Low-Molecular Weight Hyaluronic Acid in Hyaluronic Acid-Based In Situ Hydrogel Scaffold for Periodontal and Oral Wound Applications. Polymers (Basel):14(22)
Metadaten
Titel
The molecular weight of hyaluronic acid influences metabolic activity and osteogenic differentiation of periodontal ligament cells
verfasst von
Iris Frasheri
Nikoletta Dimitra Tsakiridou
Reinhard Hickel
Matthias Folwaczny
Publikationsdatum
17.08.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Oral Investigations / Ausgabe 10/2023
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-023-05202-z

Weitere Artikel der Ausgabe 10/2023

Clinical Oral Investigations 10/2023 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Zahnmedizin

Bestellen Sie unseren kostenlosen Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.